Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
103 participants
INTERVENTIONAL
2022-07-06
2025-01-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychotherapeutic Text Messaging for Depression Pilot Study
NCT02872454
A Computerized Intervention for Depression
NCT02655588
Text Messaging and Cognitive Behavioral Therapy for Depression
NCT01083628
Feasibility of a Technology-Based Treatment Support System
NCT03121937
Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy Homework
NCT00919932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
This arm will receive 8 weeks of the text-based intervention (CBT-txt). CBT-txt is a version of Cognitive Behavioral Therapy tailored to be delivered by automated text message. This arm will also complete surveys at baseline, 1 month, 2 months, and 3 months.
CBT-txt
Cognitive Behavioral Therapy delivered via automated text messaging.
Waitlist Control
This arm will not receive the text-based intervention during study participation. These participants will only complete surveys at baseline, 1 month, 2 months, and 3 months and will be given the option to receive CBT-txt after they complete study participation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT-txt
Cognitive Behavioral Therapy delivered via automated text messaging.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a score of at least 5 on the PHQ-9 (indicating elevated depression symptoms
Exclusion Criteria
* endorse suicide ideation on the PHQ-9\*
* lack of access to a text-capable phone
* unable or unwilling to commit to two months of follow-up
* not fluent in English.
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Tennessee, Knoxville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Mason
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Mason, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Tennessee-Knoxville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tennessee-Knoxville
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mason MJ, Coatsworth JD, Zaharakis N, Russell M, Brown A, McKinstry S. Testing Mechanisms of Change for Text Message-Delivered Cognitive Behavioral Therapy: Randomized Clinical Trial for Young Adult Depression. JMIR Mhealth Uhealth. 2023 Jul 11;11:e45186. doi: 10.2196/45186.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dep 2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.